Is it safe?
Can HRMY take a bad year?
Harmony Biosciences Holdings, Inc. holds $482M more cash than debt, so a bad year is a question about profits, not about lenders.
$482M
Net cash
- Net debt / EBITDA
- net cash
Net debt / EBITDA · no net borrowings to measure against earnings
- Altman Z-score
- 4.97
Altman Z-score · safe zone, above 3
- Interest cover
- 13.5×
Interest cover · operating profit covers the interest bill several times over
Details›
- Total debtQ1 2026
- $159M
- Cash and short-term investments
- $641M
- Net cash
- $482M
- Operating profit, trailing twelve months
- $190M
- Debt / equity
- 0.17×
- Annualised volatilitytwo years of daily moves
- 45%
- Worst drawdown on file
- −68%
- Below its 52-week high
- −2.1%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.